The read at a glance
Computed from the FY2025 annual filing. Full history and the components behind each score are in the app.
- Distress risk · Altman Z-Score -5.57 — distress zone — historically elevated failure riskWatch
Where the revenue comes from
Fiscal 2024, as vTv Therapeutics Inc. reports it. History and quarterly detail are in the app.
- Reportable$1.0M
Leadership changes
From vTv Therapeutics Inc.'s own filings, the day they're filed.
- Michael Tung · president · appointmenteff. 2025-05-19
- Barry K. Brown · principal financial officer · appointmenteff. 2025-04-11
- Anne Phillips · director · appointmenteff. 2024-03-12
Latest filings
- 8-K · Company announcement2026-08-06
- 10-Q · Quarterly report2026-08-06
- 8-K · Company announcement2026-06-29
- 8-K · Company announcement2026-05-13
- 8-K · Company announcement2026-05-13
In the full recordFree for 14 days
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about vTv Therapeutics Inc., every answer cited to the official filings🔒
- The Intelligence Brief — added when vTv Therapeutics Inc.'s brief passes our SEC-figure check🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.